Methotrexate, formerly known as amethopterin, is a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancies. Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma. Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's disease. It can be given by mouth or by injection.
Common side effects include nausea, feeling tired, fever, increased risk of infection, low white blood cell counts, and breakdown of the skin inside the mouth. Other side effects may include liver disease, lung disease, lymphoma, and severe skin rashes. People on long-term treatment should be regularly checked for side effects. It is not safe during breastfeeding. In those with kidney problems, lower doses may be needed. It acts by blocking the body's use of folic acid.
Methotrexate was first made in 1947 and initially was used to treat cancer, as it was less toxic than the then-current treatments. In 1956 it provided the first cures of a metastatic cancer. It is on the World Health Organization's List of Essential Medicines. Methotrexate is available as a generic medication. In 2022, it was the 132nd most commonly prescribed medication in the United States, with more than 4 million prescriptions.
|
Read full article at Wikipedia
|
InChI=1S/C16H22O4/c1-3-5-11-19-15(17)13-9-7-8-10-14(13)16(18)20-12-6-4-2/h7-10H,3-6,11-12H2,1-2H3 |
DOIRQSBPFJWKBE-UHFFFAOYSA-N |
CCCCOC(=O)c1ccccc1C(=O)OCCCC |
|
environmental contaminant
Any minor or unwanted substance introduced into the environment that can have undesired effects.
|
|
teratogenic agent
A role played by a chemical compound in biological systems with adverse consequences in embryo developments, leading to birth defects, embryo death or altered development, growth retardation and functional defect.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
EC 3.2.1.20 (alpha-glucosidase) inhibitor
An EC 3.2.1.* (glycosidase) inhibitor that interferes with the action of alpha-glucosidase (EC 3.2.1.20).
|
|
plasticiser
Any compound that is used as an additive to increase the plasticity or fluidity of a substance, particularly but not exclusively to synthetic polymers.
endocrine disruptor
Any compound that can disrupt the functions of the endocrine (hormone) system
(via phthalate ester )
|
|
View more via ChEBI Ontology
dibutyl benzene-1,2-dicarboxylate
|
1,2-Benzenedicarboxylic acid dibutyl ester
|
ChemIDplus
|
Benzene-o-dicarboxylic acid di-n-butyl ester
|
NIST Chemistry WebBook
|
Benzene-o-dicarboxylic acid di-n-butyl ester
|
ChemIDplus
|
Benzenedicarboxylic acid dibutyl ester
|
NIST Chemistry WebBook
|
Butyl phthalate
|
ChemIDplus
|
DBP
|
ChEBI
|
Di-n-butyl phthalate
|
KEGG COMPOUND
|
Dibutyl 1,2-benzenedicarboxylate
|
KEGG COMPOUND
|
Dibutyl o-phthalate
|
NIST Chemistry WebBook
|
Dibutyl phthalate
|
KEGG COMPOUND
|
Dibutyl-o-phthalate
|
ChemIDplus
|
n-Butyl phthalate
|
ChemIDplus
|
o-Benzenedicarboxylic acid dibutyl ester
|
NIST Chemistry WebBook
|
o-Benzenedicarboxylic acid dibutyl ester
|
ChemIDplus
|
Phthalic acid di-n-butyl ester
|
NIST Chemistry WebBook
|
Phthalic acid dibutyl ester
|
NIST Chemistry WebBook
|
1914064
|
Reaxys Registry Number
|
Reaxys
|
262569
|
Gmelin Registry Number
|
Gmelin
|
84-74-2
|
CAS Registry Number
|
ChemIDplus
|
84-74-2
|
CAS Registry Number
|
NIST Chemistry WebBook
|
11133400
|
PubMed citation
|
Europe PMC
|
16232742
|
PubMed citation
|
Europe PMC
|
19840837
|
PubMed citation
|
Europe PMC
|
24213843
|
PubMed citation
|
Europe PMC
|
24468924
|
PubMed citation
|
Europe PMC
|
24616073
|
PubMed citation
|
Europe PMC
|
26730679
|
PubMed citation
|
Europe PMC
|
27655612
|
PubMed citation
|
Europe PMC
|
28102498
|
PubMed citation
|
Europe PMC
|
28363850
|
PubMed citation
|
Europe PMC
|
28486587
|
PubMed citation
|
Europe PMC
|
28566680
|
PubMed citation
|
Europe PMC
|
28580302
|
PubMed citation
|
Europe PMC
|
28753974
|
PubMed citation
|
Europe PMC
|
28822891
|
PubMed citation
|
Europe PMC
|
28823096
|
PubMed citation
|
Europe PMC
|
|